Patent · US Active

Differentiating induced pluripotent stem cells into glucose-responsive, insulin-secreting progeny

US9932561B2 · kind B2 · utility

0Cited by

5References

9Claims

0Family size

Assignee

Mayo Foundation for Medical Education and Research · US

Inventors

Tayaramma Thatava · Blue Ash, US
Andre Terzic · Rochester, US
Yogish C. Kudva · Rochester, US
Yasuhiro Ikeda · Rochester, US

Key dates

Filing date	Jul 24, 2014
Grant date	Apr 3, 2018
Priority date	—
Expiry date	Jul 24, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2506/45
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

This document provides methods and materials related to differentiating iPS cells into glucose-responsive, insulin-secreting progeny. For example, methods and material for using indolactam V (ILV) and glucagon like peptide-1 (GLP-1) to produce glucose-responsive, insulin-secreting progeny from iPS cells are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.